Dabrafenib/Trametinib Approved for BRAF-Positive Anaplastic Thyroid Cancer

The approval is tremendous news and should have a profound impact on patients with the rare tumor, according to experts.

Source: CancerNetwork - May 24, 2018 Category: Cancer & Oncology Authors: John Schieszer Tags: News Thyroid Cancer Source Type: news